Applications蛋白转运抑制剂--Brefeldin A布雷非德菌素A
BFA最初曾被用作抗病毒试剂,现在在细胞生物学主要用于研究蛋白转运,也常被用于抑制细胞因子等蛋白的分泌,并用于增强分泌蛋白的免疫染色检测。
Brefeldin A布雷非德菌素A,简称BFA,是一种从真菌中分离的内酯抗生素,是蛋白质运输的特定抑制剂。BFA可抑制coat proteins(如β-COP and ADP-ribosylation factor (ARF))与高尔基体的结合并抑制GDP-GTP交换,破坏高尔基体的结构并抑制其功能,进而特异地阻断蛋白质从内质网(ER)向高尔基体(Golgi)的转运,也会导致膜蛋白分布受损。当作用于肿瘤细胞,BFA主要通过诱导分化和凋亡而发挥其细胞毒性作用。

图1.Brefeldin A化学结构式(CAS. NO: 20350-15-6)
BFA最初曾被用作抗病毒试剂,现在在细胞生物学主要用于研究蛋白转运,也常被用于抑制细胞因子等蛋白的分泌,并用于增强分泌蛋白的免疫染色检测。

图2.翌圣 50502ES03 Brefeldin A外观图
翌圣生物提供高纯度Brefeldin A布雷非德菌素A,纯度≥99%,为溶于DMSO的储存液,浓度5 mg/mL。Brefeldin A常见使用浓度范围为1-50μM。

图3.H1299细胞用Brefeldin A (5 μg/mL)处理,免疫荧光观察Hsp90a和CD63共定位情况,Brefeldin A不影响Hsp90α和CD63的膜转位。(PMID: 32640214)

图4.拟南芥幼苗用BFA (45 μM)处理0、30、60或90分钟,正常磷酸盐(NP;1.25 mM P i)或LP (0 mM P i)条件下,在BFA处理下或BFA冲洗后对BFA小体的观察和计数,结果显示:在NP和LP条件下,SNX1和SNX2a的内吞作用和胞吐作用水平相似;此外,与NP条件下相比,LP条件下PIN2的内吞和胞吐在pldζ2和snx1突变体或在PLD2抑制剂治疗下均未改。(PMID: 31745997)
产品名称 | 产品编号 | 简介 |
50502ES03 | 蛋白转运抑制剂 |
[1] Wang C, Zhang S, Liu J, et al. Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway. Cell Rep. 2020 Feb 11;30(6):1780-1797.e6. IF: 8.109
[2] Zhang S, Wang C, Ma B, et al. Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion. Cell Rep. 2020 Jul 7;32(1):107879. IF: 8.109
[3] Lin DL, Yao HY, Jia LH, et al. Phospholipase D-derived phosphatidic acid promotes root hair development under phosphorus deficiency by suppressing vacuolar degradation of PIN-FORMED2. New Phytol. 2020 Apr;226(1):142-155. IF: 7.299
[4] Ma H, Tan Y, Wen D, et al. DC-CTL targeting carbonic anhydrase IX gene combined with iAPA therapy in the treatment of renal cell carcinoma. Hum Vaccin Immunother. 2021 Nov 2;17(11):4363-4373. IF: 3.452
[5] Zhao M, Duan N, Wang Y, et al. CD5+ B lymphocytes secrete IL-10 rather than TGF-β1 which control the immune response in autoimmune haemolytic anaemia/Evans syndrome[J]. Autoimmunity. 2019 Feb;52(1):12-20. IF:2.403
[6] Shen ZY, Wu B, Liu T, et al. Immunomodulatory effects of bone marrow mesenchymal stem cells overexpressing heme oxygenase-1: Protective effects on acute rejection following reduced-size liver transplantation in a rat model. Cell Immunol. 2017 Mar;313:10-24. IF: 2.399
Not listed yet IMG FDA-approved Drug Library(FDA上市库)
Not listed yet IMG Epigenetics Compound Library(表观遗传化合物库)
Not listed yet IMG Metabolism-related Compound Library(代谢化合...
Not listed yet IMG Natural Product Library(天然产物库)
Not listed yet IMG Stem Cell Compound Library(干细胞化合物库)
Not listed yet IMG Medicine Food Homology Compound Library(...
Not listed yet IMG Tyrosine Kinase Inhibitor Compound Libra...
Not listed yet IMG Cyclo (-RGDfK)
Not listed yet IMG Eptifibatide
Not listed yet IMG Combretastatin A4
Not listed yet IMG Cyclo (RGDyK)
Not listed yet IMG ACP-196
Not listed yet IMG Cilengitide 西仑吉肽
Not listed yet IMG Zilurgisertib fumarate
Not listed yet